Okta

Posted on | by Leon Hinde | Leave a Comment on Okta

Okta, Inc. – Class A Common : Add to your watchlist & wait for the price to close above the 10-day average.

Gain exclusive access inside the investing mind of Investor Signals CEO Leon Hinde. Become a wiser investor with real-time access to Leon’s Monday night webinars, and his daily portfolio advice. 

Learn investment strategies from Leon Hinde and get a behind-scenes look at his investment portfolio. Get an investing advantage with benefits like industry-leading expert research and analysis, and proprietary technology built on AI algorithm models for both long-term investing and short-term trading. 

Start your free trial today, click here

Jamie Dimon warns U.S. economy could soon ‘deteriorate’

Posted on | by Leon Hinde | Leave a Comment on Jamie Dimon warns U.S. economy could soon ‘deteriorate’

The impacts of the pandemic-era government spending and monetary policy that helped support the U.S. economy have faded, and that makes the country vulnerable to a downturn in the coming months

“I think there’s a chance real numbers will deteriorate soon,” Dimon said at a Morgan Stanley conference on Tuesday, according to a transcript from FactSet.

Alphabet Q1 2025 Earnings

Posted on | by Leon Hinde | Leave a Comment on Alphabet Q1 2025 Earnings

Alphabet Inc. – Class C Capital is under Algo Engine buy conditions.

A $70 billion stock buyback program was unveiled.

Revenue up 12% to $90.23B , operating income up 20% to $30.61B, with operating margin climbing to 34% from a year-ago 32%.

Google Search and other, $50.7B up 9.8%

YouTube ads, $8.93B up 10.3%

Google Network, $7.26B down 2.1%

Google subscriptions, platforms and devices, $10.38B up 18.8%

Google Cloud, $12.26B up 28.1%

Other Bets, $450M down 9.1%.

Abbott Laboratories

Posted on | by Algo Engine | Leave a Comment on Abbott Laboratories

ABT:NYS is a new position opened in the US S&P 100 Trade Table.

The entry price for this position is $127.96.

Abbott Laboratories is a global healthcare company engaged in the discovery, development, manufacture, and sale of a diversified range of health care products, including cardiovascular and diabetes devices, nutritional products, diagnostic equipment, and branded generic drugs.